Ligand validation:5Y78

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
5Y78_OLC_A_508	44%	57%	0.184	0.913	0.68	0.94	1	1	1	100%	1
5Y78_OLC_B_507	31%	73%	0.164	0.898	0.22	0.78	-	-	0	64%	0.64
5Y78_OLC_B_508	31%	59%	0.195	0.876	0.72	0.82	1	1	0	92%	0.92
5Y78_OLC_B_512	31%	79%	0.149	0.93	0.12	0.73	-	-	1	36%	0.36
5Y78_OLC_A_513	27%	72%	0.16	0.9	0.26	0.78	-	-	0	48%	0.48
5Y78_OLC_B_511	25%	78%	0.164	0.913	0.12	0.76	-	-	0	36%	0.36
5Y78_OLC_A_506	24%	80%	0.172	0.923	0.13	0.7	-	-	1	32%	0.32
5Y78_OLC_B_503	23%	58%	0.198	0.82	0.68	0.91	1	1	5	100%	1
5Y78_OLC_A_514	23%	73%	0.181	0.879	0.22	0.79	-	-	0	56%	0.56
5Y78_OLC_A_512	22%	66%	0.163	0.887	0.37	0.9	-	-	0	40%	0.4
5Y78_OLC_B_525	19%	86%	0.165	0.893	0.15	0.56	-	-	1	24%	0.24
5Y78_OLC_A_503	19%	57%	0.217	0.807	0.69	0.93	1	1	1	100%	1
5Y78_OLC_A_507	18%	81%	0.162	0.875	0.14	0.67	-	-	0	28%	0.28
5Y78_OLC_A_502	16%	55%	0.239	0.804	0.68	1.02	1	1	2	100%	1
5Y78_OLC_A_511	15%	48%	0.179	0.836	0.99	1.02	1	1	2	48%	0.48
5Y78_OLC_A_505	15%	77%	0.188	0.83	0.24	0.67	-	-	2	52%	0.52
5Y78_OLC_B_509	14%	56%	0.213	0.799	0.74	0.96	1	-	0	80%	0.8
5Y78_OLC_B_517	14%	67%	0.168	0.821	0.38	0.85	-	-	2	40%	0.4
5Y78_OLC_A_515	14%	75%	0.195	0.805	0.22	0.73	-	-	1	64%	0.64
5Y78_OLC_B_504	14%	75%	0.18	0.796	0.22	0.73	-	-	0	60%	0.6
5Y78_OLC_A_504	12%	82%	0.164	0.823	0.14	0.64	-	-	0	28%	0.28
5Y78_OLC_A_517	12%	74%	0.229	0.828	0.22	0.77	-	-	2	60%	0.6
5Y78_OLC_B_513	10%	75%	0.277	0.854	0.22	0.73	-	-	1	60%	0.6
5Y78_OLC_B_506	10%	76%	0.22	0.786	0.21	0.72	-	-	1	64%	0.64
5Y78_OLC_A_510	10%	79%	0.196	0.819	0.12	0.73	-	-	1	32%	0.32
5Y78_OLC_B_514	10%	76%	0.191	0.797	0.29	0.64	-	-	0	40%	0.4
5Y78_OLC_B_502	9%	57%	0.251	0.739	0.67	0.96	1	1	2	100%	1
5Y78_OLC_B_522	9%	43%	0.239	0.828	0.99	1.25	1	1	0	44%	0.44
5Y78_OLC_B_505	8%	77%	0.263	0.853	0.11	0.79	-	-	1	36%	0.36
5Y78_OLC_B_515	8%	79%	0.227	0.808	0.12	0.73	-	-	1	36%	0.36
5Y78_OLC_B_510	7%	79%	0.218	0.794	0.12	0.73	-	-	0	32%	0.32
5Y78_OLC_B_523	6%	43%	0.263	0.809	1.03	1.24	1	1	0	40%	0.4
5Y78_OLC_B_521	5%	78%	0.2	0.732	0.12	0.76	-	-	1	36%	0.36
5Y78_OLC_A_516	5%	76%	0.28	0.755	0.21	0.72	-	-	0	68%	0.68
5Y78_OLC_B_520	4%	46%	0.224	0.69	0.94	1.18	1	1	0	52%	0.52
5Y78_OLC_B_518	4%	30%	0.262	0.709	1.76	1.16	2	-	0	56%	0.56
5Y78_OLC_A_518	4%	80%	0.277	0.761	0.13	0.7	-	-	1	32%	0.32
5Y78_OLC_B_516	3%	68%	0.276	0.727	0.32	0.89	-	-	0	44%	0.44
5Y78_OLC_B_524	3%	69%	0.266	0.71	0.32	0.85	-	-	0	44%	0.44
5Y78_OLC_B_519	2%	46%	0.254	0.651	0.99	1.14	1	-	2	44%	0.44
5Y78_OLC_A_509	2%	72%	0.304	0.674	0.22	0.83	-	-	2	52%	0.52
5Y78_OLC_B_526	2%	38%	0.326	0.706	1.17	1.35	1	2	0	32%	0.32
5Y79_OLC_A_505	39%	52%	0.156	0.906	0.79	1.08	1	1	4	76%	0.76
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	100%	1
4N6H_OLC_A_1222	62%	56%	0.117	0.932	0.81	0.87	1	1	0	88%	0.88
5IU4_OLC_A_2429	61%	58%	0.136	0.926	0.8	0.78	2	1	1	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	100%	1
7B0O_OLC_A_302	59%	55%	0.146	0.929	0.68	1.06	1	1	2	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

5Y78

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate